A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA)

201931 citationsJournal Articlegold Open Access

Authors

EudraCT Number: 2017-002056-86 ; NCT03416244 , registered: 31.1.2018.

Good health and well-being

Published in: BMC Cancer

Volume 19, Issue 1, pp. 231-231

Field-Weighted Citation Impact: 4.42